COLLEGIUM PHARMACEUTICAL, INC Quarterly Debt-to-equity in % from Q3 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Collegium Pharmaceutical, Inc quarterly Debt-to-equity history and growth rate from Q3 2015 to Q3 2024.
  • Collegium Pharmaceutical, Inc Debt-to-equity for the quarter ending September 30, 2024 was 470 %, a 12% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 470 -64.2 -12% Sep 30, 2024
Q2 2024 452 -69.7 -13.4% Jun 30, 2024
Q1 2024 483 -45.3 -8.57% Mar 31, 2024
Q4 2023 529 +9.75 +1.88% Dec 31, 2023
Q3 2023 534 +81.4 +18% Sep 30, 2023
Q2 2023 522 +159 +43.7% Jun 30, 2023
Q1 2023 528 +253 +91.6% Mar 31, 2023
Q4 2022 519 +301 +138% Dec 31, 2022
Q3 2022 452 +233 +106% Sep 30, 2022
Q2 2022 363 +124 +52.2% Jun 30, 2022
Q1 2022 276 -1.23 -0.44% Mar 31, 2022
Q4 2021 219 -73.4 -25.2% Dec 31, 2021
Q3 2021 219 -81.6 -27.1% Sep 30, 2021
Q2 2021 239 -65.2 -21.5% Jun 30, 2021
Q1 2021 277 -11.1 -3.84% Mar 31, 2021
Q4 2020 292 +41.2 +16.4% Dec 31, 2020
Q3 2020 301 +58.5 +24.1% Sep 30, 2020
Q2 2020 304 -54.6 -15.2% Jun 30, 2020
Q1 2020 288 -187 -39.4% Mar 31, 2020
Q4 2019 251 -336 -57.3% Dec 31, 2019
Q3 2019 242 -275 -53.2% Sep 30, 2019
Q2 2019 358 +23 +6.87% Jun 30, 2019
Q1 2019 475 +296 +165% Mar 31, 2019
Q4 2018 587 +560 +2043% Dec 31, 2018
Q3 2018 518 +493 +2014% Sep 30, 2018
Q2 2018 335 +310 +1226% Jun 30, 2018
Q1 2018 179 +156 +671% Mar 31, 2018
Q4 2017 27.4 +7.1 +35% Dec 31, 2017
Q3 2017 24.5 +5.34 +27.9% Sep 30, 2017
Q2 2017 25.3 +9.8 +63.3% Jun 30, 2017
Q1 2017 23.2 +10.2 +78.2% Mar 31, 2017
Q4 2016 20.3 -5.67 -21.8% Dec 31, 2016
Q3 2016 19.2 -240 -92.6% Sep 30, 2016
Q2 2016 15.5 Jun 30, 2016
Q1 2016 13 Mar 31, 2016
Q4 2015 26 Dec 31, 2015
Q3 2015 259 Sep 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.